RA CAPITAL MANAGEMENT, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (EYPT)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
EYPT
Shares outstanding
67,698,255 shares
Disclosed Ownership
3,181,818 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 18:37:58 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 4.7% ownership in EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (EYPT) on 31 Dec 2024."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (EYPT).
  • Disclosed ownership: 4.7%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 18:37.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 4.7% 3,181,818 0 3,181,818 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 4.7% 3,181,818 0 3,181,818 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 4.7% 3,181,818 0 3,181,818 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 4.7% 3,181,818 0 3,181,818 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager

Sponsored